700 LuCa-MERIT-1: First-in-human open label dose confirmation trial evaluating safety, tolerability, and efficacy of BNT116 alone and in combinations in patients with advanced non-small cell lung cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.